Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
Shai Shen-Orr, Professor at Technion – Israel Institute of Technology, shared on LinkedIn:
”For years I’ve been starting many of my talks, with imagining a world in which the question “Hey doc, how’s my immune system doing?” is a legit question.
Until now, medicine hasn’t had a good answer.
But we have reached a moment of singularity, where the tools to measure the human immune system are in place, as is the AI infrastructure, and most importantly, public awareness of the importance of understanding human immunology and human immune variation.
I’m so excited to share that the Human Immunome Project (HIP) has launched its Scientific Partner Network—the largest global collaboration in human systems immunology in history.
HIP is a bold, global infrastructure project: together we’re building the first comprehensive map of human immune diversity and function.
From this foundation, a thousand ships can launch—new diagnostics, predictive tools, and therapies that shift medicine toward prevention and true precision.
I’m honored to serve as Co-Chief Science Officer, alongside my good friend John Tsang, in the company of extraordinary partners worldwide.
This is a an effort powered by open science and collective vision. Deep gratitude to Jane Metcalfe, our chairwoman, the HIP Board, and all of our partners for their commitment and leadership.
Our founding network includes Yale University Center for Systems and Engineering Immunology, Technion – Israel Institute of Technology, Allen Institute for Immunology, Human Functional Genomics Project, HypoVax Global, RIKEN Research Center for Allergy and Immunology, Center for Human Immunology at Stanford University School of Medicine, Sustainable Sciences Institute, WEHI (Walter and Eliza Hall Institute of Medical Research), the German Center for Neurodegenerative Diseases (DZNE) and the Swarm Learning Consortium.
Together, we’re working to make “How’s my immune system doing?” a question medicine can finally answer—with high-resolution, tailored immune reference ranges, predictive risk models, and preventive strategies to keep people healthier, longer.
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin